News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,919 Results
Type
Article (41859)
Company Profile (477)
Press Release (663583)
Section
Business (208572)
Career Advice (2019)
Deals (35985)
Drug Delivery (97)
Drug Development (83421)
Employer Resources (169)
FDA (16366)
Job Trends (15066)
News (352423)
Policy (33010)
Tag
Academia (2620)
Alliances (50813)
Alzheimer's disease (1335)
Approvals (16319)
Artificial intelligence (177)
Bankruptcy (363)
Best Places to Work (11815)
Biotechnology (356)
Breast cancer (209)
Cancer (1580)
Cardiovascular disease (130)
Career advice (1683)
CAR-T (111)
Cell therapy (334)
Clinical research (66732)
Collaboration (610)
Compensation (314)
COVID-19 (2612)
C-suite (140)
Data (1503)
Diabetes (194)
Diagnostics (6262)
Earnings (86275)
Employer resources (148)
Events (113888)
Executive appointments (502)
FDA (17159)
Funding (543)
Gene therapy (235)
GLP-1 (660)
Government (4429)
Healthcare (19073)
Infectious disease (2709)
Inflammatory bowel disease (121)
Interviews (311)
IPO (16676)
Job creations (3699)
Job search strategy (1433)
Layoffs (451)
Legal (7948)
Lung cancer (233)
Manufacturing (222)
Medical device (13390)
Medtech (13395)
Mergers & acquisitions (19564)
Metabolic disorders (524)
Neuroscience (1726)
NextGen: Class of 2025 (6750)
Non-profit (4544)
Northern California (1899)
Obesity (298)
Opinion (206)
Patents (134)
People (58056)
Phase I (20957)
Phase II (29453)
Phase III (21765)
Pipeline (628)
Postmarket research (2599)
Preclinical (8949)
Radiopharmaceuticals (255)
Rare diseases (307)
Real estate (6005)
Regulatory (22250)
Research institute (2409)
Resumes & cover letters (352)
Southern California (1656)
Startups (3753)
United States (17199)
Vaccines (598)
Weight loss (212)
Date
Today (111)
Last 7 days (435)
Last 30 days (2008)
Last 365 days (35909)
2025 (1898)
2024 (36355)
2023 (41029)
2022 (52292)
2021 (56777)
2020 (54945)
2019 (47457)
2018 (35728)
2017 (33039)
2016 (32361)
2015 (38409)
2014 (32194)
2013 (27126)
2012 (29230)
2011 (29868)
2010 (27995)
Location
Africa (732)
Arizona (211)
Asia (38842)
Australia (6454)
California (4382)
Canada (1571)
China (374)
Colorado (197)
Connecticut (217)
Europe (84668)
Florida (612)
Georgia (147)
Illinois (431)
Indiana (246)
Maryland (706)
Massachusetts (3438)
Michigan (185)
Minnesota (323)
New Jersey (1215)
New York (1227)
North Carolina (851)
Northern California (1899)
Ohio (157)
Pennsylvania (1013)
South America (1109)
Southern California (1656)
Texas (640)
Utah (124)
Washington State (444)
705,919 Results for "agile therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Business
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
August 26, 2024
·
5 min read
Business
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Agile Therapeutics, Inc. (Pink: AGRX), a women’s healthcare company, today reported financial results for the three months ended March 31, 2024 and provided a corporate update.
May 15, 2024
·
14 min read
Policy
Agile Therapeutics Announces Delisting from Nasdaq - March 25, 2024
Agile Therapeutics, Inc., a women’s healthcare company, announced that the Company has received a final delisting notice from Nasdaq.
March 25, 2024
·
4 min read
Pharm Country
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Agile Therapeutics, Inc., a women’s healthcare company, announced that it has paid-off the remainder of its debt facility with Perceptive Advisors.
March 13, 2024
·
3 min read
Press Releases
Agilent Increases Cash Dividend to 24.8 Cents per Share
November 20, 2024
·
1 min read
Business
Padraig McDonnell Assumes Agilent CEO Role
Agilent Technologies Inc. announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately.
May 1, 2024
·
2 min read
Agilent Names Bret DiMarco Chief Legal Officer
Agilent Technologies, Inc. announced Bret DiMarco has been named to lead the company’s global legal organization as senior vice president and chief legal officer, as well as serving as secretary.
July 1, 2024
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Agile Therapeutics, Inc. (Pink: AGRX), a women’s healthcare company, today reported financial results for the three and twelve months ended December 31, 2023 and provided a corporate update.
March 28, 2024
·
17 min read
1 of 70,592
Next
